Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 38517826)

  • 21. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
    Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
    Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased plasma concentrations of tumour markers in the absence of neoplasia.
    Trapé J; Filella X; Alsina-Donadeu M; Juan-Pereira L; Bosch-Ferrer Á; Rigo-Bonnin R;
    Clin Chem Lab Med; 2011 Oct; 49(10):1605-20. PubMed ID: 21892908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008-2022 update.
    Trulson I; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S111-S161. PubMed ID: 37927288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.
    Nakamura H; Nishimura T
    Surg Today; 2017 Sep; 47(9):1037-1059. PubMed ID: 28229299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumor markers in lung cancer].
    Niho S; Shinkai T
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2089-93. PubMed ID: 11791391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.